Pemov Alexander, Kim Jung, Luo Wen, Liu Jia, Graham Cole, Jones Kristine, DeMangel Delphine, Freedman Neal D, Dumontet Charles, Zhu Bin, McMaster Mary L, Stewart Douglas R
Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, Bethesda, MD.
Division of Cancer Epidemiology and Genetics, Frederick National Laboratory for Cancer Research, National Cancer Institute, Rockville, MD.
Blood Neoplasia. 2024 Jun;1(2). doi: 10.1016/j.bneo.2024.100013. Epub 2024 Apr 12.
Waldenström macroglobulinemia (WM) is a rare hematological malignancy. Risk for WM is elevated 20-fold among first-degree relatives of patients with WM. However, the list of variants and genes that cause WM remains incomplete. In this study we analyzed exomes from 64 WM pedigrees for evidence of genetic susceptibility for this malignancy. We determined the frequency of pathogenic (P) or likely pathogenic (LP) variants among patients with WM; performed variant- and gene-level association analyses with the set of 166 WM cases and 681 unaffected controls; and examined the segregation pattern of deleterious variants among affected members in each pedigree. We identified P/LP variants in and (genes that function at the interface between innate immune response, genotoxic surveillance, and DNA repair) segregating in patients with WM from 2 pedigrees. There were additional P/LP variants in cancer-predisposing genes (eg, ). In variant- and gene-level analyses, no associations were statistically significant after multiple testing correction. On a pathway level, we observed involvement of genes that play a role in telomere maintenance (q-value = 0.02), regulation of innate immune response (q-value = 0.05), and DNA repair (q-value = 0.08). Affected members of each pedigree shared multiple deleterious variants (median, n = 18), but the overlap between the families was modest. In summary, P/LP variants in highly penetrant genes constitute a modest proportion of the deleterious variants; each pedigree is largely unique in its genetic architecture, and multiple genes are likely involved in the etiology of WM.
华氏巨球蛋白血症(WM)是一种罕见的血液系统恶性肿瘤。WM患者的一级亲属患WM的风险升高20倍。然而,导致WM的变异和基因列表仍不完整。在本研究中,我们分析了64个WM家系的外显子组,以寻找这种恶性肿瘤遗传易感性的证据。我们确定了WM患者中致病性(P)或可能致病性(LP)变异的频率;对166例WM病例和681例未受影响的对照进行了变异和基因水平的关联分析;并检查了每个家系中受影响成员之间有害变异的分离模式。我们在2个家系的WM患者中发现了在先天性免疫反应、基因毒性监测和DNA修复之间起作用的基因中的P/LP变异。癌症易感基因(如 )中还有其他P/LP变异。在变异和基因水平分析中,经过多重检验校正后,没有关联具有统计学意义。在通路水平上,我们观察到在端粒维持(q值 = 0.02)、先天性免疫反应调节(q值 = 0.05)和DNA修复(q值 = 0.08)中起作用的基因的参与。每个家系的受影响成员共享多个有害变异(中位数,n = 18),但家族之间的重叠程度适中。总之,高穿透性基因中的P/LP变异占有害变异的比例适中;每个家系在其遗传结构上基本是独特的,并且多个基因可能参与WM的病因。